{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:45:43Z","timestamp":1788281143634,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1053\/j.jrn.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T15:45:45Z","timestamp":1495640745000},"page":"346-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study"],"prefix":"10.1053","volume":"27","author":[{"given":"Fumihiko","family":"Koiwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Akizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2017.02.007_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00041552-200111000-00003","article-title":"Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis)","volume":"10","author":"Block","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.jrn.2017.02.007_bib2","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.02.007_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2017.02.007_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"issue":"4 suppl 3","key":"10.1053\/j.jrn.2017.02.007_bib5","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2017.02.007_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.02.007_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2017.02.007_bib8","series-title":"1st Chronic Renal Disease","first-page":"646","article-title":"Management of mineral and bone disorders in chronic kidney disease patients","author":"Jablonski","year":"2015"},{"key":"10.1053\/j.jrn.2017.02.007_bib9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.02.007_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1525-139X.2007.00299.x","article-title":"Lanthanum carbonate as a first-line phosphate binder: the \u201ccons\u201d","volume":"20","author":"Dr\u00fceke","year":"2007","journal-title":"Semin Dial"},{"key":"10.1053\/j.jrn.2017.02.007_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/C0MT00069H","article-title":"Accumulation of rare earth elements in human bone within the lifespan","volume":"3","author":"Zaichick","year":"2011","journal-title":"Metallomics"},{"key":"10.1053\/j.jrn.2017.02.007_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5414\/CNP74004","article-title":"PA21: a novel phosphate binder of the treatment of hyperphosphatemia in chronic kidney disease","volume":"74","author":"Geisser","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2017.02.007_bib13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.2014.58","article-title":"A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients","volume":"86","author":"Floege","year":"2014","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.02.007_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ndt\/gfv006","article-title":"Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients","volume":"30","author":"Floege","year":"2015","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.02.007_bib15","article-title":"Dose\u2013response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study","author":"Koiwa","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.jrn.2017.02.007_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/nep.12891","article-title":"Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomised, open-label, multicentre, 12-week Phase III study","volume":"22","author":"Koiwa","year":"2017","journal-title":"Nephrology"},{"key":"10.1053\/j.jrn.2017.02.007_bib17","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.3748\/wjg.v20.i32.11370","article-title":"Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis","volume":"20","author":"Dong","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.jrn.2017.02.007_bib18","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/ndt\/gft062","article-title":"Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"28","author":"Bailie","year":"2013","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.02.007_bib19","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/ndt\/gft280","article-title":"Serum phosphorus levels and pill burden are inversely associated with\u00a0adherence in patients on hemodialysis","volume":"29","author":"Wang","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.02.007_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life\u00a0in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227617300729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227617300729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T13:59:01Z","timestamp":1535810341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227617300729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1051227617300729"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2017.02.007","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}